Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.1 USD | +0.26% | -8.53% | -15.11% |
Business Summary
Number of employees: 10,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 1,416 | 100.0 % | 2,459 | 100.0 % | +73.65% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
45.9
%
| 503 | 35.5 % | 1,128 | 45.9 % | +124.46% |
China
44.8
%
| 840 | 59.3 % | 1,102 | 44.8 % | +31.18% |
Europe
8.2
%
| - | - | 202 | 8.2 % | - |
Rest of World
1.1
%
| 73 | 5.2 % | 27 | 1.1 % | -63.70% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,244,457,968 | 1,222,239,074 ( 98.21 %) | 0 | 98.21 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.11% | 16.01B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.69% | 21.83B | |
-10.23% | 18.18B | |
-41.92% | 16.52B | |
+6.62% | 14.14B | |
+17.53% | 10.71B | |
-30.73% | 7.6B |
- Stock Market
- Equities
- BGNE Stock
- Company BeiGene, Ltd.